No Evidence for a Major Effect of Tumor Necrosis Factor Alpha Gene Polymorphisms in Periportal Fibrosis Caused by Schistosoma mansoni Infection

Autor: Alain Dessein, Carole Eboumbou Moukoko, Nasureldin El Wali, Osman K. Saeed, Jean Gaudart, Christophe Chevillard, Qurashi Mohamed-Ali
Přispěvatelé: Génétique et immunologie des maladies parasitaires (GIMP), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), University of Gezira, Laboratoire de Mécanique des Systèmes et des Procédés (LMSP), Centre National de la Recherche Scientifique (CNRS), Aix Marseille Université (AMU), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Gaudart, Jean
Jazyk: angličtina
Rok vydání: 2003
Předmět:
medicine.medical_treatment
Sudan
Liver disease
0302 clinical medicine
Gene Frequency
[STAT.AP] Statistics [stat]/Applications [stat.AP]
Fibrosis
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
MESH: Schistosomiasis mansoni/complications
MESH: Hypertension
Portal/etiology

0303 health sciences
[STAT.AP]Statistics [stat]/Applications [stat.AP]
biology
Schistosoma japonicum
3. Good health
MESH: Sudan
Infectious Diseases
Cytokine
Liver
[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Portal hypertension
Tumor necrosis factor alpha
Schistosoma mansoni
[SDV.MP.PAR] Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology
Immunology
Schistosomiasis
Microbiology
MESH: Liver/pathology
03 medical and health sciences
Hypertension
Portal

MESH: Polymorphism
Genetic

medicine
Humans
[SDV.EE.SANT] Life Sciences [q-bio]/Ecology
environment/Health

[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology
030304 developmental biology
[SDV.EE.SANT]Life Sciences [q-bio]/Ecology
environment/Health

Polymorphism
Genetic

Base Sequence
Tumor Necrosis Factor-alpha
DNA
biology.organism_classification
medicine.disease
Schistosomiasis mansoni
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
MESH: Tumor Necrosis Factor-alpha/genetics
Parasitology
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Fungal and Parasitic Infections
030215 immunology
Zdroj: Infection and Immunity
Infection and Immunity, 2003, 71 (10), pp.5456-5460. ⟨10.1128/IAI.71.10.5456–5460.2003⟩
Infection and Immunity, American Society for Microbiology, 2003, 71 (10), pp.5456-5460. ⟨10.1128/IAI.71.10.5456–5460.2003⟩
ResearcherID
ISSN: 0019-9567
1098-5522
DOI: 10.1128/IAI.71.10.5456–5460.2003⟩
Popis: International audience; Hepatic periportal fibrosis (PPF), associated with portal hypertension, is a major pathological consequence of infections with Schistosoma mansoni and Schistosoma japonicum. Indeed, affected subjects may die from portal hypertension. Previous studies have indicated that tumor necrosis factor alpha (TNF-␣) may aggravate fibrosis. We therefore investigated whether PPF was associated with certain polymorphisms of the TNF-␣ gene. Four polymorphisms (TNF-␣ ؊376 G/A, ؊308 G/A, ؊238 G/A, and ؉488 G/A) were investigated in two Sudanese populations living in an area in which S. mansoni is endemic. These polymorphisms were analyzed for 105 Sudanese subjects with various grades of PPF, from mild to advanced; all subjects were from two neighboring villages (Taweela and Umzukra). They were then analyzed for 70 subjects with advanced liver disease and for 345 matched controls from the Gezira region. We found no evidence of associations between these four polymorphisms and PPF in both of these studies. Thus, these four polymorphisms, two of which (TNF-␣ ؊376 and ؊308) were found to increase TNF-␣ gene transcription, are unlikely to have a major effect on PPF progression in these populations. However, this result does not exclude the possibility that these polymorphisms have a minor effect on PPF development. Schistosomiasis is a serious public health problem affecting over 200 million people in developing countries (15, 41). Most of the infections occurring in areas where schistosomes are endemic are asymptomatic. However, 5 to 15% of infected individuals develop severe disease with Symmers fibrosis. Schistosomes (Schistosoma mansoni) produce several hundred eggs per day, and a proportion of these eggs are trapped in hepatic tissues and in presinusoidal venules. There, they induce a granulomatous inflammation that leads, in certain subjects , to the accumulation of scar tissue in the periportal spaces. Periportal fibrosis (PPF) causes venous obstruction and portal blood hypertension and contributes to the development of splenomegaly. Severely affected patients develop esopha-geal varices, ascites, and cachexia, resulting in death in the absence of treatment. Fibrosis, which involves stellate (Ito) cells derived from fibroblasts, results from an imbalance between the positive and negative regulatory mechanisms controlling the production and degradation of extracellular matrix proteins (ECMP). The production of collagen and ECMP is stimulated by a variety of cytokines and growth factors (inter-leukin-1 [IL-1], IL-4, IL-13, tumor necrosis factor alpha [TNF-␣]), monocyte chemotactic protein 1, platelet-derived growth factors, and transforming growth factor ␤), which stimulate fibroblast differentiation and the production of ECMP by fi-broblasts, Kupffer cells, and endothelial cells (14, 16, 22, 30). Other cytokines, such as alpha interferon (IFN-␣) and IFN-␥
Databáze: OpenAIRE